PortugalPortugal

Council to decide on novel EU standard on DNA profiles from criminal offenders

12.06.2009

Forensic scientists have laid the groundwork to expand and harmonise the exchange of the roughly 6 million DNA fingerprints from criminal offenders that are currently stored in national DNA databases throughout the European Union. The European DNA Profiling Group (EDNAP) and the European Network of Forensic Science Institutes (ENFSI) recommended upping the current European standard set (ESS) for DNA profiling of short tandem repeats (STRs) – the non-coding DNA sequences used to confirm identity – from 7 to 12. The decision has now been passed on to the contact group at the European Council that will decide on the new standard in the second half of the year, and the upcoming Swedish EU presidency has already agreed to put the issue on its priority list. The move is aimed at harmonising the STR set used in forensic labs, as well as improving the robustness and sensitivity of tests, thereby avoiding any random matches that could link DNA profiles of criminal offenders to innocent EU citizens.
The idea of expanding the standard set emerged more than four years ago, when 10 EU countries signed the Prum Treaty, an extra-EU agreement that defines rules for automatic exchange of DNA sets to track cross-border crime between those nations. After 6 additional EU countries declared they also intend to join the Treaty, the European Council last year decided to incorporate it into EU law.
“The Council decision commits the EU member states to establish national DNA databases and automatic data exchange by 2011,” Dr. Rainer Wenzel from German State Office of Criminal Investigation (LKA) in Mainz told EuroBiotechNews. “And with a growing number of DNA datasets being exchanged, the statistical probability of random matches is also growing.”
According to analyses from ENFSI, which established the current standard in 1999, the 6 million DNA datasets stored in national DNA police registers is set to grow as new countries join in. “At the moment Austria, Germany, Spain, Slovenia, Luxembourg, and the Netherlands already automatically exchange STR profiles, and France and Finland are joining soon,” confirmed Wenzel.

STR suppliers feel well-prepared

At their meeting in Lisbon, ENFSI and EDNAP recommended adding three very short mini-STRs and two midi-STRs to the standard set to make the DNA tests more robust, more sensitive, and more effective at finding matches even in highly degraded samples. “The new standard will have a greater capacity to discriminate very similar DNA profiles, or to match STRs of degraded or very small samples,” said German forensic expert Dr. Mark Benecke.
According to Wenzel, forensic labs would be able to implement new multiplex kits covering the 12 STRs a few weeks after they have come to the market. “We will be able to deliver multiplex kits with the new standard plus the additional very meaningful marker SE33 by the end of the year,” said Dr. Peter Quick, who views his company Promega as well-positioned to provide STR systems to meet anticipated market demands. Promega’s competitor Life Technologies will also offer 12+X STRs kits, but without SE33. Together, Life Technologies and Promega already share more than two thirds of the worldwide human identity testing market. Amidst fierce competition, it’s unlikely that costs will rise with the new multiplex kits.
According to Wenzel, STR profiles already provide hit rates of up to 30% in identifying cross-border criminality, and will become more accurate with the standard. Interestingly, most of the felons apprehended using the technology are not terrorists, murderers or other perpetrators of violent crimes. Instead, it has proven most effective at catching burglars.

PortugalPortugal

19.08.2008

Lisbon – The international contract research organisation Chiltern sees potential for growth in Portugal. In May, it opened a new office in Lisbon that will be managed by Ricardo Diaz. Over the last two years, numbers of clinical...

PortugalPortugal

19.03.2008

Porto – 164 farmers planted a total of 4,199 hectares of genetically modified maize in Portugal in 2007, according to a report issued by the Portuguese Ministry of Agriculture. That represents a 330% increase compared to 2006,...

PortugalPortugal

22.11.2007

Cantanhede – Biogen Idec (Cambridge, US) and the Portuguese biopark Biocant in the Coimbra region have signed a socalled ‘Sponsored Research Agreement’ worth an undisclosed amount. Under the terms of the agreement, researchers...

Portugal, SpainPortugal

11.07.2007

Oeiras/Navarra – Portuguese antibody and genomics specialist Biotecnol SA and the Spanish university spin-off Digna Biotech will develop a process for manufacturing cardiotrophin-1 (CT-1) for the treatment of ischemic-reperfusion...

PortugalPortugal

11.07.2007

Porto – In September 2005, the Portuguese government established a decree law (No. 160/2005) on the co-existence between genetically modified organisms (GMO), conventional and organic crops. In short, it recommends a minimum...

PortugalPortugal

11.07.2007

Almada – transADVANcis Lda, a consultancy firm for nanotechnology and life sciences executives, has launched a website called www.nanogolive.com. With the new portal, on which anyone from the nanotechnology and life science...

PortugalPortugal

16.05.2007

Porto – Two Portuguese biotech companies have won the national idea contest for bio-entrepreneurs (Concurso de Ideias Bioempreendedor 2006), organized every year by the Portuguese Association of Bioindustries (APBio) and the...

PortugalPortugal

16.03.2007

Port Salvo – Biotrend S.A., developers of high-value compounds based in Lisbon, has closed a second investment round with the public venture capital outfit PME Investimientos, ending with a total investment exceeding 1 million...

PortugalPortugal

16.03.2007

Porto Salvo – Alfama, developers of small molecule drugs, has opened a laboratory in Boston, Massachusetts, in order to achieve US presence. The company will carry out research on the effects of self-developed molecules on...

Italy, PortugalPortugal

16.09.2006

Milan/Sintra – The Italian pharmaceutical company Recordati S.p.A agreed in July to acquire Jaba Farmacêutica (Sintra, Portugal) and all other pharmaceutical businesses belonging to the Grupo Jaba in Portugal. The purchase price...

Displaying results 11 to 20 out of 37

< Previous 11-20 Next >

© 2007-2014 BIOCOM

http://www.european-biotechnology-news.com/nc/news/messages-archive/archive-portugal/browse/1/article/council-to-decide-on-novel-eu-standard-on-dna-profiles-from-criminal-offenders.html

Events

All Events

Stock list

All quotes

TOP

  • 4SC1.17 EUR0.00%
  • ACTELION109.60 CHF0.00%
  • ADDEX3.10 CHF0.00%

FLOP

  • CYTOTOOLS31.45 EUR-0.47%
  • 4SC1.17 EUR0.00%
  • ACTELION109.60 CHF0.00%

TOP

  • CO.DON3.32 EUR32.8%
  • EPIGENOMICS3.83 EUR23.5%
  • PAION3.05 EUR23.0%

FLOP

  • ADDEX3.10 CHF-22.5%
  • EVOTEC3.08 EUR-16.1%
  • MEDIGENE3.93 EUR-15.5%

TOP

  • SANTHERA88.05 CHF2058.1%
  • CO.DON3.32 EUR286.0%
  • PAION3.05 EUR202.0%

FLOP

  • CYTOS0.24 CHF-94.0%
  • BIOFRONTERA2.20 EUR-39.7%
  • MERCK KGAA68.48 EUR-39.7%

No liability assumed, Date: 20.09.2014


Current issue

All issues

Product of the week

Products